Last reviewed · How we verify

Calmoseptine Ointment

University of the Philippines · FDA-approved active Small molecule

Calmoseptine Ointment creates a protective barrier on skin while providing antimicrobial and anti-inflammatory effects to promote wound healing and prevent infection.

Calmoseptine Ointment creates a protective barrier on skin while providing antimicrobial and anti-inflammatory effects to promote wound healing and prevent infection. Used for Diaper dermatitis and nappy rash, Minor cuts, abrasions, and skin irritations, Pressure ulcer prevention and treatment.

At a glance

Generic nameCalmoseptine Ointment
Also known asCalmoseptine
SponsorUniversity of the Philippines
Drug classTopical antimicrobial and protective ointment
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

The ointment combines a water-repellent base with bismuth subnitrate and zinc oxide to form a protective layer against moisture and irritants. It has antimicrobial properties that help prevent bacterial colonization of wounds while reducing inflammation and promoting epithelialization of damaged skin.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: